Literature DB >> 6220072

Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.

D Y Leung, E T Chu, N Wood, S Grady, R Meade, R S Geha.   

Abstract

We recently demonstrated that during the acute phase of mucocutaneous lymph node syndrome (MCLS)3 there was a significant reduction in circulating T8+ suppressor/cytotoxic T cells and an increased number of Ia/Dr-bearing T4+ T cells, which suggests the presence of circulating activated helper T cells (1). Furthermore, the vast majority of patients with acute MCLS had a significantly elevated number of circulating B cells spontaneously secreting IgG and IgM. In the present study, the possible role of the immunoregulatory T cell abnormalities in the polyclonal B cell activation was investigated by assaying the ability of T cells and T cell factors from patients with acute MCLS to induce immunoglobulin production by normal B lymphocytes. We also examined the capacity of normal T cells to suppress immunoglobulin production by activated B cells from patients with acute MCLS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Antineutrophil cytoplasm antibodies in Kawasaki disease.

Authors:  C O Savage; J Tizard; D Jayne; C M Lockwood; M J Dillon
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

2.  Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

Authors:  S Kobayashi; N Wada; M Kubo
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

Review 3.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 4.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 5.  Kawasaki disease: recent advances.

Authors:  M Levin; E J Tizard; M J Dillon
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

6.  Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.

Authors:  E R Wann; A P Fehringer; Y V Ezepchuk; P M Schlievert; P Bina; R F Reiser; M M Höök; D Y Leung
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease.

Authors:  J Hirao; K Sugita
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 8.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

9.  Human herpesvirus 6 infection and Kawasaki disease.

Authors:  M Okano; J Luka; G M Thiele; Y Sakiyama; S Matsumoto; D T Purtilo
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

10.  Immunological studies on Kawasaki disease. I. Appearance of Hanganutziu-Deicher antibodies.

Authors:  M Takiguchi; T Tamura; M Goto; S Kusakawa; F Milgrom; K Kano
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.